ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ALGS Aligos Therapeutics Inc

0,7907
-0,0553 (-6,54%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aligos Therapeutics Inc ALGS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0553 -6,54% 0,7907 06:00:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,829 0,7811 0,85 0,8101 0,846
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:05GLOBEAligos Therapeutics to Announce 1st Quarter 2024 Financial..
25.4.202422:05GLOBEAligos Therapeutics Presents Positive Clinical Data at..
25.4.202414:00GLOBEAligos Therapeutics Mourns the Passing of MASH Industry..
09.4.202414:00GLOBEAligos Therapeutics to Participate in the Piper Sandler..
03.4.202414:00GLOBEAligos Therapeutics Announces First Subjects Dosed in the..
27.3.202413:00GLOBEAligos Therapeutics Presents Positive Clinical Data at APASL..
18.3.202413:00GLOBEAligos Therapeutics Announces the Initiation of the Phase 2a..
12.3.202421:05GLOBEAligos Therapeutics Reports Recent Business Progress..
05.3.202422:05GLOBEAligos Therapeutics to Announce 4th Quarter 2023 Financial..
04.3.202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202414:00GLOBEAligos Therapeutics To Participate in the Leerink Partners..
20.2.202414:00GLOBEAligos Therapeutics to Host KOL Event to Discuss Phase 2a..
13.2.202414:00GLOBEAligos Therapeutics Strengthens Finance Leadership Team with..
30.1.202413:04EDGAR2Form SC TO-I - Tender offer statement by Issuer
25.1.202412:12EDGAR2Form SC TO-C - Written communication relating to an issuer..
25.1.202412:06EDGAR2Form 8-K - Current report
28.11.202322:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22.11.202322:05EDGAR2Form 8-K - Current report
17.11.202322:38EDGAR2Form S-3 - Registration statement under Securities Act of..
15.11.202322:01EDGAR2Form 8-K - Current report
07.11.202318:03EDGAR2Form D - Notice of Exempt Offering of Securities
02.11.202321:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.11.202321:05EDGAR2Form 8-K - Current report
25.10.202323:05EDGAR2Form 8-K - Current report
18.10.202314:45EDGAR2Form 8-K - Current report
12.9.202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202322:01EDGAR2Form 8-K - Current report
03.8.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:05EDGAR2Form 8-K - Current report
01.8.202322:52EDGAR2Form 8-K - Current report
25.7.202322:02EDGAR2Form 8-K - Current report
21.7.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock